Varian announced that it will be attending the UBS Global Healthcare Conference and the 2019 RBC Capital Markets Healthcare Conference in New York City.
PALO ALTO, Calif., May 7, 2019 /PRNewswire/ -- Varian (NYSE: VAR) today announced that it will be attending the UBS Global Healthcare Conference (May 20-22) and the 2019 RBC Capital Markets Healthcare Conference (May 21-22) in New York City.
- Gary Bischoping - Chief Financial Officer and J. Michael Bruff - SVP, Finance and Investor Relations, will be attending the UBS Global Healthcare Conference on May 21.
- Chris Toth - President, Varian Oncology Systems and J. Michael Bruff - SVP, Finance and Investor Relations, will be attending the 2019 RBC Capital Markets Healthcare Conference on May 22.
Information about the webcast of the company’s presentation will be available through a link on the company website at www.varian.com/investors.
About Varian
Varian is a leader in developing and delivering cancer care solutions and is focused on creating a world without fear of cancer. Headquartered in Palo Alto, California, Varian employs approximately 7,000 people around the world. For more information, visit http://www.varian.com and follow @VarianMedSys on Twitter.
Investor Relations Contact
J. Michael Bruff
Senior Vice President, Investor Relations
+1 (650) 424-5163
investors@varian.com
Press Contact
Mark Plungy
Director, Public Relations
+1 (650) 424-5630
mark.plungy@varian.com
View original content:http://www.prnewswire.com/news-releases/varian-to-attend-upcoming-investor-events-300845631.html
SOURCE Varian
Company Codes: NYSE:VAR
